210 related articles for article (PubMed ID: 35134807)
1. Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma.
Sekino N; Kano M; Kobayashi S; Murakami K; Sakata H; Toyozumi T; Endo S; Matsumoto Y; Suito H; Takahashi M; Otsuka R; Yokoyama M; Shiraishi T; Okada K; Kamata T; Ryuzaki T; Hirasawa S; Kinoshita K; Sasaki T; Iida K; Komatsu A; Matsubara H
Oncology; 2022; 100(5):267-277. PubMed ID: 35134807
[TBL] [Abstract][Full Text] [Related]
2. Caspase recruitment domain family member 9 expression is a promising biomarker in esophageal squamous cell carcinoma.
Sekino N; Kano M; Sakata H; Murakami K; Toyozumi T; Matsumoto Y; Ryuzaki T; Ikeda J; Ota M; Matsubara H
Ann Gastroenterol Surg; 2020 Mar; 4(2):135-141. PubMed ID: 32258978
[TBL] [Abstract][Full Text] [Related]
3. Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.
Yang Q; Luo GY; Li Y; Shan HB; Wang HY; Xu GL
Med Oncol; 2013 Dec; 30(4):689. PubMed ID: 24026656
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.
Zhang H; Chen W; Duan CJ; Zhang CF
World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267
[TBL] [Abstract][Full Text] [Related]
5. Increased STX3 transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patients.
Shinozuka T; Kanda M; Sato Y; Shimizu D; Tanaka C; Umeda S; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Cancer Med; 2023 Dec; 12(24):22185-22195. PubMed ID: 38014487
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
7. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
Lee HW; Kwon J; Kang MC; Noh MK; Koh JS; Kim JH; Park JH
Dis Esophagus; 2016 Oct; 29(7):848-855. PubMed ID: 25953518
[TBL] [Abstract][Full Text] [Related]
9. Risk Stratification by Tissue
Kishida T; Kanda M; Sato Y; Shimizu D; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Kodera Y
Cancer Genomics Proteomics; 2023; 20(6):617-625. PubMed ID: 37889064
[TBL] [Abstract][Full Text] [Related]
10. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.
Pan F; Yao J; Chen Y; Zhou C; Geng P; Mao H; Fang X
Int J Clin Exp Pathol; 2014; 7(6):2838-49. PubMed ID: 25031703
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
[TBL] [Abstract][Full Text] [Related]
12. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
14. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
16. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
17. High FN1 expression is associated with poor survival in esophageal squamous cell carcinoma.
Ma J; Chen S; Su M; Wang W
Medicine (Baltimore); 2023 Apr; 102(14):e33388. PubMed ID: 37026938
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
[TBL] [Abstract][Full Text] [Related]
19. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
Liang F; Wang YG; Wang C
Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
[TBL] [Abstract][Full Text] [Related]
20. Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.
Umeda S; Kanda M; Koike M; Tanaka H; Miwa T; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Kodera Y
Oncol Rep; 2018 Dec; 40(6):3772-3780. PubMed ID: 30272363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
